Fundraising FoxMizMaa Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Flox provides tooling to manage software and its dependencies down to individual packages, including SBOMs and provenance, with reproducible environments that work across the software lifecycle.
AI & Machine LearningCloud ComputingCybersecurityDeveloper ToolsEnterprise SoftwareNew York City, US
Ron Efroni Rotman(Executive Officer, Director)Michael Brantley(CTO)inRon Efroni(CEO)inBen Futoriansky(Executive Officer)in
BoardAaron Jacobson(Director)inPavel Livshiz(Director)in
Co-investorsHetz VenturesNew Enterprise Associates (NEA)Angel Collective Opportunity FundEssence Venture CapitalFirestreak VenturesMaximilian Stoiber+6 more
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms.
BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness
Chris Mirabile(Founder & CEO)in
Co-investorsCornucopian Capital ManagementFab Co-Creation Studio VenturesResolute VenturesUNCOMMON DENOMINATORKaedan CapitalRemagine Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.